FORM 8.3 - AON PLC - Amendment

FORM 8.3 - AON PLC - Amendment

BARCLAYS PLC

 

FORM 8.3 - Amendment to Sales

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) Barclays PLC.
Company dealt in AON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 22 May 2020

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security: ORD
Long Short
Number (%) Number (%)

(1)

Relevant securities

254,578

0.11%

884,311

0.38%

 

(2)

Derivatives (other than options):

466,239

0.20%

29,700

0.01%

 

(3)

Options and agreements to
purchase/sell:

2,600

0.00%

4,500

0.00%

 
TOTAL:

723,417

0.31%

918,511

0.40%

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale Number of relevant securities Price per unit

Purchase

4

191.6325 USD

Purchase

9

191.6733 USD

Purchase

9

191.7266 USD

Purchase

11

191.6263 USD

Purchase

12

191.5575 USD

Purchase

21

191.4866 USD

Purchase

22

191.5900 USD

Purchase

11

193.3300 USD

Purchase

24

191.6722 USD

Purchase

25

191.6628 USD

Purchase

29

191.6677 USD

Purchase

100

191.7700 USD

Purchase

100

193.1500 USD

Purchase

100

192.3100 USD

Purchase

100

191.8649 USD

Purchase

102

192.3516 USD

Purchase

200

192.4800 USD

Purchase

210

191.8109 USD

Purchase

226

191.8815 USD

Purchase

258

192.0154 USD

Purchase

292

191.9263 USD

Purchase

399

192.9541 USD

Purchase

400

192.1700 USD

Purchase

500

192.2570 USD

Purchase

600

191.6992 USD

Purchase

610

192.0726 USD

Purchase

629

191.8260 USD

Purchase

640

191.1293 USD

Purchase

700

192.1850 USD

Purchase

800

192.0412 USD

Purchase

900

192.2244 USD

Purchase

1,392

191.7598 USD

Purchase

1,475

191.9110 USD

Purchase

1,867

191.9681 USD

Purchase

2,040

191.9157 USD

Purchase

2,709

192.0231 USD

Purchase

2,900

191.8331 USD

Purchase

3,206

191.9368 USD

Purchase

3,226

191.8156 USD

Purchase

3,716

192.1298 USD

Purchase

3,739

191.9051 USD

Purchase

4,910

192.0168 USD

Purchase

5,646

191.9624 USD

Purchase

8,264

191.9700 USD

Purchase

21,469

191.8771 USD

Purchase

26,007

191.8882 USD

Sale

1

192.2200 USD

Sale

5

192.0880 USD

Sale

5

191.9100 USD

Sale

10

191.8600 USD

Sale

10

191.9780 USD

Sale

11

191.0300 USD

Sale

18

191.8483 USD

Sale

19

191.7852 USD

Sale

22

191.8563 USD

Sale

25

191.6750 USD

Sale

35

191.7900 USD

Sale

35

192.2800 USD

Sale

59

191.6600 USD

Sale

104

193.1175 USD

Sale

109

191.9742 USD

Sale

120

191.1366 USD

Sale

160

191.6110 USD

Sale

200

192.4800 USD

Sale

209

192.2700 USD

Sale

256

192.1442 USD

Sale

318

191.6066 USD

Sale

320

191.1293 USD

Sale

326

191.8473 USD

Sale

500

191.6320 USD

Sale

600

191.6992 USD

Sale

700

192.1850 USD

Sale

718

192.7468 USD

Sale

1,100

192.0136 USD

Sale

1,754

191.9042 USD

Sale

1,904

191.9991 USD

Sale

2,000

191.7985 USD

Sale

2,005

191.9077 USD

Sale

2,388

191.6556 USD

Sale

19,970

191.9700 USD

Sale

63,540

191.8982 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached?

YES

Date of disclosure:

26 May 2020

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection

 

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates

Call Options

Purchased

1,100

260.0000

American

Jul 17, 2020

Call Options

Purchased

1,500

240.0000

American

Jul 17, 2020

Call Options

Written

-4,500

220.0000

American

Jul 17, 2020

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

UK 100

Latest directors dealings